Innovations for the Infectious Disease and Oncology market
ZeptoMetrix® is the industry leader for innovative solutions to challenges in the evolving Infectious Disease and Oncology market. Their reputation for product quality, reliability, and trusted technical knowledge provides assurance that enables industry to develop and advance diagnostics technologies. From assay conception to launch, ZeptoMetrix' scientific and operational teams provide their customers with comprehensive, performance-oriented and cost-effective products and services that positively impact the field of clinical diagnostics and its contribution to global healthcare.
ZeptoMetrix manufactures and provides an extensive range of quality controls and verification panels for Nucleic Acid Testing (NAT) and serological and antigen-based assays. Products that are treated with ZeptoMetrix' exclusive, patented NATtrol™ process represent industry-leading choices for NAT, creating the benchmark for external quality controls and verification materials found within the diagnostic testing industry. NATtrol products originate from highly purified microorganisms which are processed to alter surface proteins, resulting in products that are in an optimal state for research and testing: with intact nucleic acids, these products are non-infectious, refrigerator stable, and work with a wide variety of PCR-based assay systems. NATtrol products serve as the optimal proficiency testing option as they permit total cycle evaluation in NAT, from DNA extraction to amplification and detection.
- Coronavirus products for assay development
- Molecular controls and panels for infectious disease testing
- Biological materials and reagents for assay development
- Clinical specimens and seroconversion panels
- Microorganisms: evolving collection of over 1200 strains
- Antibodies, kits and reagents